Responses
Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
399 A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.